Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease.
Journal Information
Full Title: Ann Neurol
Abbreviation: Ann Neurol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Potential Conflicts of Interest M.R., E.A.V., E.M.M., X.L., G.G.Z.Z., P.T.M., D.S., R.A.C., B.P.E., W.L., M.F.F., and P.R.K.: AbbVie employees and may hold stock or options. F.J.: AbbVie employee at the time this work was conducted and may hold stock or options."
Funding Disclosure
Evidence found in paper:
"This study was sponsored by AbbVie, Inc. AbbVie provided review and approval of the study design and this publication. Wesley Wayman, PhD, an employee of AbbVie, collated the manuscript and provided copyediting support."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025